Glucagon-Like Peptide-1 Receptor Agonists and Alcohol Use: A Real-Word Observational Study in a Large, Integrated Health Care System
GLP-1RAs may be effective in reducing average weekly alcohol consumption, even in individuals with low-risk use. The small subsample of individuals with high-risk use limited our ability to estimate associations in this group.
Authors
- Vanessa A. Palzes (ORCID: https://orcid.org/0000-0002-3256-579X)
- Andrea H. Kline‐Simon (ORCID: https://orcid.org/0000-0002-6303-7308)
- Brianna Costales (ORCID: https://orcid.org/0000-0002-5334-2712)
- Lorenzo Leggio (ORCID: https://orcid.org/0000-0001-7284-8754)
- Stacy Sterling (ORCID: https://orcid.org/0000-0002-6987-8423)
- Mehdi Farokhnia (ORCID: https://orcid.org/0000-0003-0902-4212)
Institutions
- National Institute on Drug Abuse (US)
- Kaiser Permanente (US)
- Johns Hopkins University (US)
- University of California, San Francisco (US)
- Georgetown University (US)
- Brown University (US)
- Johns Hopkins Medicine (US)
- Georgetown University Medical Center (US)
- National Institute on Alcohol Abuse and Alcoholism (US)
Publication Details
- Journal
- Biological Psychiatry Global Open Science
- Published
- 2025-11-24
- DOI
- https://doi.org/10.1016/j.bpsgos.2025.100659
- Citations
- 2
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 2.59